CLVLF Stock Price, Chart, Stats & News
Clinuvel Pharmaceuticals Limited (CLVLF) is a dividend-paying stock with a current dividend yield of 0.90% as of Aug 21, 2026. It pays $0.0654 per share over the trailing twelve months. Its dividend has grown at a 29.17% 5-year compound annual rate.
Dividend safety
Dividend coverage looks healthy — CLVLF pays out about 15% of earnings.
CLVLF chart
About
Clinuvel Pharmaceuticals Limited (CLVLF), an Australian biopharmaceutical firm established in Melbourne in 1987, specializes in the creation and global marketing of therapeutic solutions. Its primary focus is on patients suffering from genetic, metabolic, and severe, life-threatening conditions, with operations spanning Australia, Europe, the United States, Switzerland, and various international markets. The company's flagship product is SCENESSE, a systemic photoprotective medication.
Related lists
Similar securities
Based on sector and market capitalization
